AXONKLINIKKEN AS

Axonklinikken | Effektiv og trygg behandling mot psykiske lidelser | Oslo | Trondheim

Oppdag trygg og effektiv behandling for angst, depresjon, og PTSD ved Axonklinikken i Oslo og Trondheim. Lang erfaring, kort ventetid og enkel booking.

Keywords

nurseschiropractorshomeopathsmidwivesacupuncturistspodiatristspsychotherapistsoccupational therapistsaromatherapistsreflexology therapistselectrotherapistsmagnetic therapistsgestalt therapistsnaturopathskinesiologistsspeech therapists

Organization

CEO: HW
Håkon Weløy Aarseth1991
Chairman of the board: ØG
Øyvind Gjærevoll Schanke1968
Years since formation: 7 years; since Jul 3, 2018
Type: Limited company
VAT registered: Yes
Number of employees: 16

Ownership

Number of shares and share classes: 269,442; 1 share class
Total number of shareholders: 13; 8 companies, 5 persons

Financials

Total operating income 2023: 8,519,755; NOK
Annual total result 2023: -7,459,661; NOK
Total equity 2023: 841,807; NOK

Last update: Jun 11, 2025

Management

Management / administration

Name	Role	Shares
HW Håkon Weløy Aarseth 1991	Managing Director/CEO	-

Board

Name	Role	Shares
LH Lowan Han Stewart 1975	Board Member	8.35 % directly
ØG Øyvind Gjærevoll Schanke 1968	Chairman	4.12 % indirectly
SV Silje Veen 1971	Board Member	4.95 % indirectly

Others

Name	Role	Shares
C CROWE PARTNER REVISJON AS	Auditor	-

Top 10 individual shareholders

Name	Role	Shares
TD Tor Dagfinn Veen 1947	-	12.1 % indirectly
IC Ingrid Castberg 1967	-	8.35 % directly
LH Lowan Han Stewart 1975	Board Member	8.35 % directly
KS Kjell Skappel 1977	-	8.25 % indirectly
JV Julian Veen Uldal 1997	-	6.36 % indirectly
LV Leo Veen Røe 2004	-	6.36 % indirectly
LV Lars Veen Uldal 1999	-	6.36 % indirectly
SV Silje Veen 1971	Board Member	4.95 % indirectly
CV Camilla Veen 1975	-	4.95 % indirectly
ØG Øyvind Gjærevoll Schanke 1968	Chairman	4.12 % indirectly

Last update: Feb 19, 2025

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
T T.D. VEEN AS	Ordinary shares	133,333	49.48 %
LH Lowan Han Stewart 1975	Ordinary shares	22,500	8.35 %
IC Ingrid Castberg 1967	Ordinary shares	22,500	8.35 %
S STAVANGER VENTURE AS	Ordinary shares	22,222	8.25 %
NS Nasakkah Sarl	Ordinary shares	22,222	8.25 %
S SCHANKE HOLDING AS	Ordinary shares	11,111	4.12 %
1 1337 INVEST AS	Ordinary shares	8,888	3.3 %
I INTOLA HOLDING AS	Ordinary shares	5,556	2.06 %
KA Kjell Aage Moe Torp-Joakimsen 1969	Ordinary shares	5,556	2.06 %
M MINDE HOLDING AS	Ordinary shares	4,444	1.65 %
N NANNA SJAASTAD AS	Ordinary shares	4,444	1.65 %
S SNUSFONDET AS	Ordinary shares	4,444	1.65 %
SA Samir Anis Rostom Yassa Ayman 1976	Ordinary shares	2,222	0.82 %

Last update: Jun 2, 2025

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	8,519,755	4,232,270	3,401,750
Annual Total Result	-7,459,661	-4,558,473	-116,463
Total assets	3,630,150	5,612,457	909,331
Total liabilities	2,788,342	9,933,549	671,949
Total equity	841,807	-4,321,091	237,381

P&L

Year	2023	2022	2021
Total operating income	8,519,755	4,232,270	3,401,750
Total operating costs	16,001,239	8,729,544	3,515,890
Operating result	-7,481,485	-4,497,274	-114,140
Financial income/costs	21,824	-61,198	-2,323
Profit before tax	-7,459,661	-4,558,473	-116,463
Total tax & extraordinary income/cost	0	0	0
Annual Total Result	-7,459,661	-4,558,473	-116,463

Balance overview

Year	2023	2022	2021
Total fixed assets	628,501	107,992	121,419
Total current assets	3,001,648	5,504,465	787,912
Total assets	3,630,150	5,612,457	909,331
Short term debt	2,788,342	5,443,773	671,949
Long term debt	0	4,489,776	0
Total liabilities	2,788,342	9,933,549	671,949
Contributed capital	6,647,109	24,430	24,430
Retained earnings	-5,805,302	-4,345,521	212,951
Total equity	841,807	-4,321,091	237,381
Total equity and liabilities	3,630,149	5,612,458	909,331

AXONKLINIKKEN AS921 108 338